Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation
- 1 December 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (3) , 782-790
- https://doi.org/10.1046/j.1365-2141.2000.02419.x
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Isolation of Highly Purified Autologous and Allogeneic Peripheral CD34+ Cells Using the CliniMACS DeviceJournal of Hematotherapy, 1999
- Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV diseaseBone Marrow Transplantation, 1997
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the DonorNew England Journal of Medicine, 1995
- Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantationThe Lancet, 1994
- Therapeutic Reconstitution of Human Viral Immunity by Adoptive Transfer of Cytotoxic T Lymphocyte ClonesPublished by Springer Nature ,1994
- Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow TransplantAnnals of Internal Medicine, 1993
- Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow TransplantsAnnals of Internal Medicine, 1988
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986
- Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' ExperienceClinical Infectious Diseases, 1982